Childhood-Onset Myasthenia Gravis, a Troublesome Clinical Entity with Heterogeneity in China (ANN) - Iris Publishers
Childhood-Onset Myasthenia Gravis, a Troublesome Clinical Entity with Heterogeneity in China (ANN) - Iris Publishers
Childhood-Onset Myasthenia Gravis, a Troublesome Clinical Entity with Heterogeneity in China (ANN) - Iris Publishers
Myasthenia gravis (MG) is a well-known autoimmune disease involving neuromuscular transmission leading to fluctuating muscle weakness and fatigability. With the advent of immunotherapy, majority of MG sufferers will have a good outcome. However, the childhood onset MG (CMG) in China is quite different from that reported in the Western countries in light of onset age distribution, clinical types, responsiveness to immunotherapy and the long-term outcome. The mini-review focuses on the differences of Chinese CMG patients from European cases.
For more Iris
Publishers Open Access Journals Please visit our website:
https://irispublishers.com/
https://irispublishers.com/
For more Neurology
& Neuroscience best research topics articles Please Click Here: https://irispublishers.com/ann/
No comments:
Post a Comment